4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011547
Director sold 2,000 shares at $65.45 ($130,900)
- Director acquired 2,000 shares (option exercise)
- Director acquired 1,504 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HERSHBERG ROBERT · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-14 | Grant or award : show line 1 in the form | +1,504 | 1,504 | D | ||
| 2021-02-16 | Exercise or conversion : show line 2 in the form | +2,000 | $0.45 | $900 | 3,504 | D |
| 2021-02-16 | Sale : show line 3 in the form | −2,000 | $65.45 | $130,900 | 1,504 | D |
| Open-market sales · 2,000 sh · avg $65.45 · $130,900 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +3,759 | 3,759 | D |
| 2021-02-16 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −2,000 | 55,000 | D |
Loading xslF345X03/doc4.xml…